2 related articles

OpenAI launches GPT-Rosalind, an enterprise AI model for life sciences. Integrating GPT-5.5 agentic coding and tool use, it covers drug discovery, molecular design, data analysis, and experimental workflows.

OpenAI launches GPT-Rosalind, its first frontier AI model for biology, drug discovery, and translational medicine. A deep dive into its capabilities, trusted access deployment, and industry impact.